NDC 63323-132 – Mitoxantrone
Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution · Intravenous
Product NDC63323-132
Product details
- Brand name
- Mitoxantrone
- Generic name
- Mitoxantrone Hydrochloride
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA077496
- Marketed since
- April 11, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Mitoxantrone Hydrochloride 2 mg/mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 63323-132-10 | 1 VIAL, MULTI-DOSE in 1 BOX (63323-132-10) / 10 mL in 1 VIAL, MULTI-DOSE | Apr 11, 2006 |
| 63323-132-12 | 1 VIAL, MULTI-DOSE in 1 BOX (63323-132-12) / 12.5 mL in 1 VIAL, MULTI-DOSE | Apr 11, 2006 |
| 63323-132-15 | 1 VIAL, MULTI-DOSE in 1 BOX (63323-132-15) / 15 mL in 1 VIAL, MULTI-DOSE | Apr 11, 2006 |
Other mitoXANTRONE products
- 61703-343 Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution, Concentrate · Hospira, Inc.
- 71288-178 Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-179 Mitoxantrone Hydrochloride 2 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.